论文部分内容阅读
肝硬化患者处于明显肝功能受损状态,机体蛋白合成能力、凝血因子合成速度均明显变化,凝血功能严重异常,呈现一种获得性高凝状态,血栓形成风险较高。本研究对利伐沙班与华法林对骨关节炎合并肝硬化患者抗凝治疗中出血风险的影响进行分析。1资料与方法1.1一般资料选本院2014年5月至2015年5月收治的116例骨关节炎合并肝硬化患者,按照随机数字表法分为利伐沙班组与华法林组,各58例。两组患
Patients with cirrhosis were significantly impaired hepatic function, the body protein synthesis capacity, coagulation factor synthesis rate were significantly changed, coagulation dysfunction, showing an acquired hypercoagulable state, a higher risk of thrombosis. This study analyzed the effects of rivaroxaban and warfarin on the risk of bleeding during anticoagulation in patients with osteoarthritis and cirrhosis. 1 Materials and Methods 1.1 General Information Selected 116 cases of patients with osteoarthritis and cirrhosis admitted to our hospital from May 2014 to May 2015 were divided into rivaroxaban group and warfarin group according to random number table method, example. Two groups of patients